CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Aura Biosciences Inc   (AURA)
Other Ticker:  
 

Aura Biosciences Inc 's Leverage Ratio

AURA's quarterly Leverage Ratio and Total Liabilities, Equity growth




AURA Leverage Ratio (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Equity Change 27.76 % 28.41 % - - -
Y / Y Total Liabilities Change 382.78 % 896.91 % 393.9 % - -
Leverage Ratio MRQ 0.14 0.14 0.24 0.05 0.04
Overall Ranking # 337 # 419 # 758 # 135 # 111
Seq. Equity Change -7.84 % 69.99 % -10.87 % -8.5 % -7.37 %
Seq. Total Liabilities Change -9.14 % 0.92 % 373.74 % 11.13 % 87.62 %

New: More AURA's historic Leverage Ratio results >>


Comment on AURA Leverage Ratio in the first quarter 2023
Due to repayements of liabilities of -9.14% Aura Biosciences Inc improved Leverage Ratio in first quarter 2023 to 0.14, above the Aura Biosciences Inc 's average Leverage Ratio.

Within Biotechnology & Pharmaceuticals industry in the first quarter 2023, 43 other companies have achieved lower Leverage Ratio than Aura Biosciences Inc in the I Quarter 2023. While total ranking remained the same in the first quarter 2023 compared to the previous quarter at no. .

Explain Leverage Ratio?
Who are AURA Customers?
What are AURA´s Total Liabilities?
Leverage Ratio first quarter 2023 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 44
Healthcare Sector # 186
Overall Market # 337


Leverage Ratio Statistics
High Average Low
0.24 0.11 0.02
(Sep 30 2022)  




Financial Statements
Aura Biosciences Inc 's Equity $ 180 Millions Visit AURA's Balance sheet
Aura Biosciences Inc 's Total Liabilities $ 26 Millions Visit AURA's Balance sheet
Source of AURA's Sales Visit AURA's Sales by Geography


Cumulative Aura Biosciences Inc 's Leverage Ratio

AURA's Leverage Ratio for the trailling 12 Months

AURA Leverage Ratio

 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Equity TTM Growth 27.76 % 28.41 % - - -
Y / Y Total Liabilities TTM Growth 382.78 % 896.91 % 393.9 % - -
Leverage Ratio TTM 0.14 0.12 0.08 0.07 0.09
Total Ranking TTM # 2 # 2 # 186 # 1540 # 1487
Seq. Equity TTM Growth -7.84 % 69.99 % -10.87 % -8.5 % -7.37 %
Seq. Total Liabilities TTM Growth -9.14 % 0.92 % 373.74 % 11.13 % 87.62 %

Leverage ratio ranking by company, industry and sector >> Back to AURA Financial Strength Comparisons >> Compare AURA Leverage Ratio to its Peers

TTM Leverage Ratio Comment
On the trailing twelve months basis Despite of the repayements of liabilities of -9.14% in the trailling twelve months ending in I Quarter 2023, Leverage Ratio improved to 0.14, below Aura Biosciences Inc 's average Leverage Ratio.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry AURA recorded the lowest Leverage Ratio. While total ranking remained unchanged compared to previous 12 month period at no. 2.

Explain Leverage Ratio?
Who are AURA Customers?
What are AURA´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 0
Healthcare Sector # 1
Within the Market # 2


TTM Leverage Ratio Statistics
High Average Low
0.83 0.39 0.09
(Jun 30 2022)   (Sep 30 2022)




Companies with similar Leverage Ratio in the quarter ending Mar 31 2023, within Biotechnology & Pharmaceuticals Industry Leverage RatioMar 31 2023 MRQ Total LiabilitiesMar 31 2023 MRQ Equity
Eargo Inc   0.39 $ 32.170  Millions$ 82.340  Millions
Gritstone Bio Inc   0.39 $ 54.499  Millions$ 140.878  Millions
Black Diamond Therapeutics Inc   0.38 $ 37.392  Millions$ 98.190  Millions
Vicarious Surgical Inc   0.38 $ 33.362  Millions$ 87.728  Millions
Biomerica Inc   0.37 $ 2.224  Millions$ 5.986  Millions
Vericel Corporation  0.37 $ 71.118  Millions$ 193.978  Millions
Vir Biotechnology Inc   0.35 $ 695.179  Millions$ 1,970.801  Millions
Predictive Oncology Inc   0.35 $ 6.507  Millions$ 18.554  Millions
Lifeloc Technologies Inc   0.34 $ 2.074  Millions$ 6.101  Millions
Inmune Bio Inc   0.34 $ 18.683  Millions$ 55.296  Millions
Precipio inc   0.34 $ 4.779  Millions$ 14.225  Millions
Inogen Inc   0.33 $ 92.013  Millions$ 281.297  Millions
Avanos Medical Inc   0.33 $ 424.100  Millions$ 1,298.700  Millions
Sangamo Therapeutics Inc   0.31 $ 104.957  Millions$ 335.610  Millions
Fusion Pharmaceuticals Inc   0.30 $ 61.080  Millions$ 200.833  Millions
Repligen Corp  0.30 $ 589.783  Millions$ 1,940.492  Millions
Milestone Scientific Inc   0.30 $ 2.791  Millions$ 9.252  Millions
Scholar Rock Holding Corp  0.30 $ 68.400  Millions$ 228.653  Millions
Adverum Biotechnologies Inc   0.29 $ 46.472  Millions$ 157.757  Millions
Moderna Inc   0.28 $ 5,262.000  Millions$ 18,863.000  Millions
Cognition Therapeutics inc   0.28 $ 9.880  Millions$ 35.783  Millions
Omega Therapeutics Inc   0.27 $ 33.315  Millions$ 123.000  Millions
Bio techne Corp  0.27 $ 511.163  Millions$ 1,889.686  Millions
Monte Rosa Therapeutics Inc   0.27 $ 65.302  Millions$ 243.726  Millions
Bionano Genomics Inc   0.26 $ 60.664  Millions$ 231.487  Millions
Seagen Inc   0.26 $ 713.228  Millions$ 2,723.156  Millions
Allogene Therapeutics Inc   0.26 $ 154.609  Millions$ 592.262  Millions
Allovir Inc   0.26 $ 50.512  Millions$ 193.532  Millions
Scientific Industries Inc   0.25 $ 3.295  Millions$ 13.069  Millions
Passage Bio inc   0.25 $ 42.892  Millions$ 170.351  Millions

Date modified: 2023-05-14T12:48:18+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071